| P50 | author | Lina Jankauskaite | Q90575830 |
| | Aiste Pociute | Q92523580 |
| P2093 | author name string | Rimantas Kevalas | |
| | Mantas Malinauskas | |
| | Jithin Thomas | |
| P2860 | cites work | Identification of potential diagnostic biomarkers for pneumonia caused by adenovirus infection in children by screening serum exosomal microRNAs | Q64104024 |
| | The diagnostic accuracy of high-mobility group box 1 protein and twelve other markers in discriminating bacterial, viral and co-infected bronchial pneumonia in Han children | Q83167781 |
| | Lectin Microarray Combined with Mass Spectrometry Identifies Haptoglobin-Related Protein (HPR) as a Potential Serologic Biomarker for Separating Nonbacterial Pneumonia from Bacterial Pneumonia in Childhood | Q88767450 |
| | Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006-2015 | Q90387159 |
| | Overview of the biology of type I interferons | Q21195364 |
| | Epidemiology and etiology of childhood pneumonia | Q22241278 |
| | Approach to the patient with neutropenia in childhood | Q26777106 |
| | The power of data mining in diagnosis of childhood pneumonia | Q27339291 |
| | Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study | Q30252707 |
| | Discovery and validation of biomarkers to guide clinical management of pneumonia in African children | Q33678141 |
| | Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia | Q33714041 |
| | Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia. | Q36083137 |
| | Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia | Q36192583 |
| | Office pediatrics: current perspectives on the outpatient evaluation and management of lower respiratory infections in children | Q36392808 |
| | Community-acquired pneumonia requiring hospitalization among U.S. children | Q36420016 |
| | Type I interferons: diversity of sources, production pathways and effects on immune responses | Q36611339 |
| | Neutropenia in pediatric practice | Q37048093 |
| | Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine | Q37351374 |
| | Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014. | Q37739619 |
| | Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity | Q37821936 |
| | British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. | Q37929444 |
| | Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling | Q38301869 |
| | Biomarkers in Pediatric Community-Acquired Pneumonia | Q39144356 |
| | The complete blood count and leukocyte differential count. An approach to their rational application | Q39750816 |
| | Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections | Q40046231 |
| | Clinical significance of serum procalcitonin level monitoring on early diagnosis of severe pneumonia on children | Q40883007 |
| | Diagnosis of viral infections using myxovirus resistance protein A (MxA). | Q41391190 |
| | The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis | Q42206098 |
| | Utility of inflammatory markers in predicting the aetiology of pneumonia in children | Q42214005 |
| | Community-acquired pneumonia in children; the challenges of microbiological diagnosis. | Q47566059 |
| | Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come? | Q47641206 |
| | Pediatric Community-Acquired Pneumonia in the United States: Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research | Q47768505 |
| | Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses | Q49239889 |
| | Changing Epidemiology of Haemophilus influenzae in Children | Q49887696 |
| | Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study | Q56917368 |
| | Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia | Q58697957 |
| | YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children | Q59793438 |
| | Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis* | Q60692857 |
| | Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children | Q64083649 |
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| | bacterial pneumonia | Q3776920 |
| P304 | page(s) | 4 | |
| P577 | publication date | 2020-01-09 | |
| P1433 | published in | Italian Journal of Paediatrics | Q15762169 |
| P1476 | title | Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review | |
| P478 | volume | 46 | |